Dr. Ford Brewer MD MPH · 2026-08-20 · Ford Brewer (host), Jesus Vega
The Shocking Truth About Taurine and Arterial Plaque: New Evidence
44 research-tied claims examined: 1 contradicted 1 overstated 4 context 32 supported 6 unverified
6 No source found (not proven false)
In rabbits fed a high-cholesterol diet for 8 months and then returned to normal chow for 4 months, adding taurine to drinking water led to a slight additional slowing/retardation of plaque lesions compared to diet cessation alone, without significant lipid differences.
"they fed rabbits an enormous cholesterol load for eight months... When they stopped feeding the animals, the rabbits, they put them back on normal chow, rabbit chow, for four months, and gave half of them taurine in the drinking water... the taurine group showed a slight additional slowing or retardation of the lesion or the plaque. "Slight" is the author's own words, and there were no significant differences in the lipid measures between the two recovery groups." (said at 0:08:40)
No published record matching the specific experimental protocol (rabbits fed a high-cholesterol diet for 8 months followed by 4 months of normal chow with taurine in drinking water assessing lesion retardation and lipid levels) was located; this does not prove the claim false. Related animal literature in cholesterol-fed rabbits and hyperlipidemic models indicates that taurine supplementation can reduce atherosclerotic lesion area without necessarily altering circulating lipid profiles, but the exact study design described was not identified.
In a 2025 randomized, double-blind, placebo-controlled trial of 165 people with type 2 diabetes given 2.4 g/day of taurine for 12 weeks, systolic blood pressure dropped ~7 mmHg, flow-mediated dilation improved, platelet calcium influx dropped, and plasma hydrogen sulfide roughly doubled.
"165 people, type 2 diabetes, randomized to 2.4 grams of taurine a day split as 0.8 grams three times a day... or in the control group, placebo. You look at this in 12 weeks after this different exposure... Against placebo, systolic pressure came down about seven points. Flow-mediated dilation improved... Calcium influx into the platelets dropped... Plasma hydrogen sulfide roughly doubled." (said at 0:11:45)
No published record matching a 2025 randomized controlled trial of 165 individuals with type 2 diabetes receiving 2.4 g/day of taurine for 12 weeks and evaluating systolic blood pressure, flow-mediated dilation, platelet calcium influx, and plasma hydrogen sulfide was located; this does not prove the claim false.
In a 2024 study on mice with surgically injured carotid arteries, taurine administration (50 mg/kg for 4 days) reduced plaque area but decreased collagen in the plaque cap and lowered the smooth muscle cell to macrophage ratio.
"There's a 2024 finding that complicates all of this... Mice carotid arteries in a model where the artery is surgically injured to force the disease to develop fast. Taurine by tube, 50 milligrams per kilogram for four days. The plaque area decreased, but the cap over that plaque had less collagen. It was unstable. So the ratio of smooth muscle cells to macrophages, the immune cells, dropped." (said at 0:14:56)
No published record matching the claimed 2024 mouse carotid artery injury study—where taurine administration (50 mg/kg for 4 days) reportedly reduced plaque area while decreasing fibrous cap collagen and reducing the smooth muscle cell to macrophage ratio—was located; this does not prove the claim false.
Pharmaceutical companies developed statins, Vascepa, and aspirin by modifying naturally occurring substances/supplements to obtain FDA prescription approval.
"Big Pharma clearly keeps an eye on what's going on in the supplement industry because they often take a supplement and turn it into a medication. That's what they did with statins. That's what they did with... Vascepa... Aspirin." (said at 0:24:21)
No published record matching the claim that pharmaceutical companies developed statins, Vascepa, and aspirin by modifying naturally occurring dietary supplements to obtain FDA prescription approval was located; this does not prove the claim false.
A 2024 mouse study found that taurine caused plaque shrinking while damaging the fibrous cap of the plaque through an effect on collagen.
"that 2024 study in mice that you mentioned where there is a shrinking of plaque, but it was also what was damaging the cap of the plaque, that wasn't necessarily related to to platelets. It was related to the impact on collagen." (said at 0:37:24)
No published record matching a 2024 mouse study demonstrating that taurine reduced atherosclerotic plaque size while simultaneously damaging or thinning the fibrous cap through collagen disruption was located; this does not prove the claim false.
Studies in mice, rabbits, and in vitro models show that small dense LDL particles are highly inflammatory.
"There is plenty of evidence on mice, on rabbits, and the lab that shows that small LDL particles are highly inflammatory." (said at 0:38:15)
No published record matching the claim that studies in mice, rabbits, and in vitro models show small dense LDL particles are highly inflammatory was located; this does not prove the claim false.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.